Trial intelligence / Profile preview

Postoperative hydrocodone vs sufentanil analgesia after laparoscopic colorectal surgery

ChiCTR2500097500Phase 4Not yet recruiting

Sponsor
Yixing People's Hospital
Start
Feb 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in colorectal cancer (CRC) comparing Hydrocodone IV analgesia with Sufentanil IV analgesia (2 arms). Primary endpoint: Quality of recovery (QoR-15 score). Planned start Feb 2025; status: not yet recruiting.

02

Drugs

hydrocodonesufentanil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on ChiCTR2500097500.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500097500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call